 |
Work set to start on Bahrain medical complexBahraini authorities said work would soon begin on a BD1.7-million ($4.5 million) multiple sclerosis centre in the Muharraq region of the kingdom. The 100-bed facility, being developed as part of the Muharraq Medical Complex, is set for completi More… |
|
Work set to start on Bahrain medical complexBahraini authorities said work would soon begin on a BD1.7-million ($4.5 million) multiple sclerosis centre in the Muharraq region of the kingdom. The 100-bed facility, being developed as part of the Muharraq Medical Complex, is set for completi More… |
 |
Merck's drug for multiple sclerosis wins UAE approvalUS pharma group Merck said the UAE Ministry of Health and Prevention has approved the registration of its Mavenclad (cladribine tablets) for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clini More… |
|
Merck's drug for multiple sclerosis wins UAE approvalUS pharma group Merck said the UAE Ministry of Health and Prevention has approved the registration of its Mavenclad (cladribine tablets) for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clini More… |
 |
Global experts to discuss MS research in DubaiNeurologists from across the world will discuss the latest research and trends in multiple sclerosis (MS) at an upcoming congress in Dubai. The first MENACTRIMS Congress will be organised by the Middle East North Africa Committee More… |
 |
University of Ain Shams opens MS treatment unitThe University of Ain Shams, in cooperation with Novartis Pharmaceuticals, has opened Egypt’s first medical unit for the treatment of multiple sclerosis (MS). An autoimmune disease that affects the central nervous system, MS More… |
|
University of Ain Shams opens MS treatment unitThe University of Ain Shams, in cooperation with Novartis Pharmaceuticals, has opened Egypt’s first medical unit for the treatment of multiple sclerosis (MS). An autoimmune disease that affects the central nervous system, MS More… |
 |
MS Egypt Chapter urges public awarenessThe MS Chapter of the Egyptian Society of Neurology, Psychiatry, and Neurosurgery (ESNPN), urged better public understanding of the disease that affects 2.5 million people worldwide, on the occasion of World Multiple Sclerosis (MS) Day. More… |
 |
Sanofi says MS treatment reduced relapse rateSanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m More… |
 |
Kuwait societies aim to raise MS awarenessTwo major medical and cultural societies in Kuwait have joined hands with local experts to raise awareness of the neurological disorder Multiple Sclerosis (MS) through a series of educational talks. “Most of the MS information on the Inter More… |
